UK pharma association the ABPI has warned that the government’s planned value-based pricing system for medicines will not necessarily save the NHS money.
Speaking at the Wellards health conference, ABPI director general Richard Barker said: “There is this unrealistic belief in the government’s mind that the result is that prices will fall, but I don’t think we know, actually.
“Value based pricing is thoroughly logical, but not a magic bullet,” Barker added.
via inpharm.com
